← Back to Search

Device

Portable Internal Airway Percussion device for Cystic Fibrosis

N/A

Recruiting

Led By Silvia Delgado Villalta, MD

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14 days

Awards & highlights

Study Summary

This trial compares two airway clearance devices used to treat cystic fibrosis. It aims to find if one is better than the other, and if not, provides an alternative device which is cheaper and portable.

Eligible Conditions

Cystic Fibrosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 14 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~14 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To measure the number of cystic fibrosis patients perception of breathing effort and device use

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PIAPD-Portable Internal Airway Percussion deviceExperimental Treatment1 Intervention

There will be an Inpatient Arm and Outpatient Arm using the Smart One® portable home spirometer

Group II: SACD-Standard Airway Clearance deviceActive Control1 Intervention

There will be an Inpatient Arm and Outpatient Arm using the SACD. A large majority of patients will be using VEST therapy as their standard of care airway clearance. A few might be using an Intrapulmonary Percussion Device that uses a mechanism different from the device the study will be testing.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,340 Previous Clinical Trials

715,650 Total Patients Enrolled

8 Trials studying Cystic Fibrosis

426 Patients Enrolled for Cystic Fibrosis

Silvia Delgado Villalta, MDPrincipal InvestigatorUniversity of Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants aged 65+ eligible to enrol in this clinical trial?

"This clinical trial necessitates individuals aged from 6 to 21 years old. Additionally, 85 trials are being conducted for those under 18 and 380 for those over 65."

Answered by AI

What criteria must individuals meet in order to qualify for participation in this clinical trial?

"This study requires participants to fit a specific demographic criteria, namely those between 6 and 21 years old who have cystic fibrosis. Currently, the research team is seeking out around 55 individuals for this trial."

Answered by AI

Are there any openings still available for participants in this research project?

"According to the info hosted on clinicaltrials.gov, this medical trial is currently closed for recruitment and has not been updated since November 22nd 2021. However, there are still 424 other active studies looking for patients in the system."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Airway Clearance for Pediatric and Adult Cystic Fibrosis Patients Using a Portable Intra-Pulmonary Percussion Device

2021. "Airway Clearance for Pediatric and Adult Cystic Fibrosis Patients Using a Portable Intra-Pulmonary Percussion Device". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04743206.

All > Cystic Fibrosis